Cargando…

Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)

Viral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. For the past 100 years, viral associated respiratory epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyfoori, Amir, Shokrollahi Barough, Mahdieh, Mokarram, Pooneh, Ahmadi, Mazaher, Mehrbod, Parvaneh, Sheidary, Alireza, Madrakian, Tayyebeh, Kiumarsi, Mohammad, Walsh, Tavia, McAlinden, Kielan D., Ghosh, Chandra C., Sharma, Pawan, Zeki, Amir A., Ghavami, Saeid, Akbari, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269337/
https://www.ncbi.nlm.nih.gov/pubmed/34203268
http://dx.doi.org/10.3390/ijms22136937
_version_ 1783720556794740736
author Seyfoori, Amir
Shokrollahi Barough, Mahdieh
Mokarram, Pooneh
Ahmadi, Mazaher
Mehrbod, Parvaneh
Sheidary, Alireza
Madrakian, Tayyebeh
Kiumarsi, Mohammad
Walsh, Tavia
McAlinden, Kielan D.
Ghosh, Chandra C.
Sharma, Pawan
Zeki, Amir A.
Ghavami, Saeid
Akbari, Mohsen
author_facet Seyfoori, Amir
Shokrollahi Barough, Mahdieh
Mokarram, Pooneh
Ahmadi, Mazaher
Mehrbod, Parvaneh
Sheidary, Alireza
Madrakian, Tayyebeh
Kiumarsi, Mohammad
Walsh, Tavia
McAlinden, Kielan D.
Ghosh, Chandra C.
Sharma, Pawan
Zeki, Amir A.
Ghavami, Saeid
Akbari, Mohsen
author_sort Seyfoori, Amir
collection PubMed
description Viral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. For the past 100 years, viral associated respiratory epidemics have been the most common cause of infectious disease worldwide. Due to several drawbacks of the current anti-viral treatments, such as drug resistance generation and non-targeting of viral proteins, the development of novel nanotherapeutic or nano-vaccine strategies can be considered essential. Due to their specific physical and biological properties, nanoparticles hold promising opportunities for both anti-viral treatments and vaccines against viral infections. Besides the specific physiological properties of the respiratory system, there is a significant demand for utilizing nano-designs in the production of vaccines or antiviral agents for airway-localized administration. SARS-CoV-2, as an immediate example of respiratory viruses, is an enveloped, positive-sense, single-stranded RNA virus belonging to the coronaviridae family. COVID-19 can lead to acute respiratory distress syndrome, similarly to other members of the coronaviridae. Hence, reviewing the current and past emerging nanotechnology-based medications on similar respiratory viral diseases can identify pathways towards generating novel SARS-CoV-2 nanotherapeutics and/or nano-vaccines.
format Online
Article
Text
id pubmed-8269337
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82693372021-07-10 Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID) Seyfoori, Amir Shokrollahi Barough, Mahdieh Mokarram, Pooneh Ahmadi, Mazaher Mehrbod, Parvaneh Sheidary, Alireza Madrakian, Tayyebeh Kiumarsi, Mohammad Walsh, Tavia McAlinden, Kielan D. Ghosh, Chandra C. Sharma, Pawan Zeki, Amir A. Ghavami, Saeid Akbari, Mohsen Int J Mol Sci Review Viral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. For the past 100 years, viral associated respiratory epidemics have been the most common cause of infectious disease worldwide. Due to several drawbacks of the current anti-viral treatments, such as drug resistance generation and non-targeting of viral proteins, the development of novel nanotherapeutic or nano-vaccine strategies can be considered essential. Due to their specific physical and biological properties, nanoparticles hold promising opportunities for both anti-viral treatments and vaccines against viral infections. Besides the specific physiological properties of the respiratory system, there is a significant demand for utilizing nano-designs in the production of vaccines or antiviral agents for airway-localized administration. SARS-CoV-2, as an immediate example of respiratory viruses, is an enveloped, positive-sense, single-stranded RNA virus belonging to the coronaviridae family. COVID-19 can lead to acute respiratory distress syndrome, similarly to other members of the coronaviridae. Hence, reviewing the current and past emerging nanotechnology-based medications on similar respiratory viral diseases can identify pathways towards generating novel SARS-CoV-2 nanotherapeutics and/or nano-vaccines. MDPI 2021-06-28 /pmc/articles/PMC8269337/ /pubmed/34203268 http://dx.doi.org/10.3390/ijms22136937 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Seyfoori, Amir
Shokrollahi Barough, Mahdieh
Mokarram, Pooneh
Ahmadi, Mazaher
Mehrbod, Parvaneh
Sheidary, Alireza
Madrakian, Tayyebeh
Kiumarsi, Mohammad
Walsh, Tavia
McAlinden, Kielan D.
Ghosh, Chandra C.
Sharma, Pawan
Zeki, Amir A.
Ghavami, Saeid
Akbari, Mohsen
Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)
title Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)
title_full Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)
title_fullStr Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)
title_full_unstemmed Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)
title_short Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)
title_sort emerging advances of nanotechnology in drug and vaccine delivery against viral associated respiratory infectious diseases (varid)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269337/
https://www.ncbi.nlm.nih.gov/pubmed/34203268
http://dx.doi.org/10.3390/ijms22136937
work_keys_str_mv AT seyfooriamir emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT shokrollahibaroughmahdieh emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT mokarrampooneh emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT ahmadimazaher emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT mehrbodparvaneh emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT sheidaryalireza emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT madrakiantayyebeh emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT kiumarsimohammad emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT walshtavia emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT mcalindenkieland emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT ghoshchandrac emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT sharmapawan emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT zekiamira emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT ghavamisaeid emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid
AT akbarimohsen emergingadvancesofnanotechnologyindrugandvaccinedeliveryagainstviralassociatedrespiratoryinfectiousdiseasesvarid